Cocrystal Pharma (COCP) Net Cash Flow (2010 - 2026)
Cocrystal Pharma (COCP) posted Net Cash Flow of -$2.3 million for Q1 2026, down 228.65% sequentially from -$712000.0 in Q4 2025, and up 20.38% YoY from -$1.9 million in Q1 2025.
Cocrystal Pharma (COCP) Net Cash Flow (2010 - 2026) Analysis & Trends
Cocrystal Pharma has reported Net Cash Flow for 16 years, with the latest figure at -$2.3 million in Q1 2026.
- Quarterly Net Cash Flow rose 20.38% year-over-year to -$2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.6 million (up 55.97% YoY) and the FY2025 annual result came in at -$2.8 million, up 82.76% from the prior year.
- Net Cash Flow eased to -$2.3 million in Q1 2026 per COCP's latest filing, from -$712000.0 in the prior quarter.
- Over five years, Net Cash Flow peaked at -$712000.0 in Q4 2025 and troughed at -$8.9 million in Q3 2022.
- A 5-year average of -$3.4 million and a median of -$3.2 million in 2023 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2022 and 2025: Net Cash Flow sank 1561.19% in 2022, then soared 77.47% in 2025.
- Over 5 years, Net Cash Flow stood at -$4.9 million in 2022, then jumped by 31.09% to -$3.4 million in 2023, then climbed by 6.65% to -$3.2 million in 2024, then jumped by 77.47% to -$712000.0 in 2025, then sank by 228.65% to -$2.3 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$2.3 million, -$712000.0, and -$1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.03 Bn | 131.18 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.64 Bn | 77.64 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.93 Bn | 59.75 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.93 Bn | 52.80 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.95 Bn | 36.86 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.51 Bn | 28.20 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 28.00 Bn | 9.60 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 225.59 Mn |
| 10 | Cocrystal Pharma | 15.51 Mn | 13.19 Mn | - | -2.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.52 Mn |
| Jun 30, 2026 | -2.52 Mn |
| Mar 31, 2026 | -2.34 Mn |
| Mar 31, 2026 | -2.34 Mn |
| Dec 31, 2025 | -712,000.00 |
| Dec 31, 2025 | -712,000.00 |
| Sep 30, 2025 | -1.36 Mn |
| Sep 30, 2025 | -1.36 Mn |
| Jun 30, 2025 | -2.16 Mn |
| Jun 30, 2025 | -2.16 Mn |
| Mar 31, 2025 | -2.94 Mn |
| Mar 31, 2025 | -2.94 Mn |
| Dec 31, 2024 | -3.16 Mn |
| Dec 31, 2024 | -3.16 Mn |
| Sep 30, 2024 | -5.12 Mn |
| Sep 30, 2024 | -5.12 Mn |
| Jun 30, 2024 | -3.70 Mn |
| Jun 30, 2024 | -3.70 Mn |
| Mar 31, 2024 | -4.51 Mn |
| Mar 31, 2024 | -4.51 Mn |